Characterization of pancreatic and biliary cancer stem cells in patient-derived tissue
Objectives Pancreatic ductal adenocarcinoma (PDAC) and extrahepatic cholangiocarcinoma (eCC) represent two of the most lethal cancer entities. Cancer stem cells (CSCs) have been identified as crucial for tumor growth, metastasis, chemoresistance and thus represent a potential therapeutic target.
Source: Pancreatology - Category: Gastroenterology Authors: Rosa Schmuck, Julia Gogolok, Elisabeth Seidel, Anja Schirmeier, Andreas Andreou, Thomas Malinka, Fritz Klein, Johann Pratschke, Marcus Bahra Tags: 9. Experimental pancreatic cancer I Source Type: research
More News: Adenocarcinoma | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Pancreas | Pancreatic Cancer | Stem Cell Therapy | Stem Cells